Hepatocyte growth factor (HGF) is implicated in placental development; hgfr and hgf null mutant embryos develop placental insufficiency and lethality at 11.5 days (E11.5) after fertilization. The function of HGF in placentation at implantation (E4.5) has not been studied. Using reverse transcription-polymerase chain reaction, we detected HGF receptor (HGFR) mRNA in preimplantation embryos and in cultured blastocyst outgrowths. HGFR protein was detected in trophoblast cells in blastocyst outgrowths. HGF mRNA was not detected at these stages but was detected in the uterus at E5.5. Using in situ hybridization, we detected HGF mRNA in the mesometrial uterus, near the embryo, from E6.5 through E8.5. At E8.5, HGFR mRNA was detected in the chorionic placenta, and HGF mRNA was detected in the allantois. The expression for HGF and HGFR suggested a maternal-to-embryonic communication before the development of the allantois. To test this, blastocyst outgrowths were cultured with HGF. HGF stimulated the outgrowth of trophoblasts in a time-dependent manner and stimulated the expression of proliferating cell nuclear antigen, but it did not scatter trophoblasts. HGF stimulated an increase in the trophoblast cell number, but caused a decrease in the total number of terminally differentiated trophoblasts expressing placental lactogen-1 protein. These data suggest that HGF stimulates the cell division, but not the differentiation, of trophoblast cells during implantation.
INTRODUCTION
In mammals, the periimplantation period is the time of greatest embryonic failure and loss [1] . In this period, the embryonic and extraembryonic yolk sac and placental cell lineages are determined and become essential for survival [2] . In humans, failure to form a placenta properly leads to the clinically important conditions preeclampsia and intrauterine growth retardation (IUGR). In the mouse, fibroblast growth factor (FGF)-4, colony stimulating factor-1, insulinlike growth factor/insulin, and hepatocyte growth factor (HGF) have been implicated in placental development [2, 3] . The essential function of HGF was first detected at the end of gastrulation (E8.5) and became rate-limiting at E11.5 [4, 5] , when the lethality of null hgf and hgfr mutant embryos began.
HGF is implicated in the development of the placenta, liver, and somite-derived skeletal muscle after gastrulation [6] . HGF is expressed in the mesenchyme, and the HGF receptor (HGFR) is expressed in epithelia. HGF acts as a mitogen, morphogen, inducer, and motogen in many in vitro and in vivo models. During human placental development, HGF has been detected in the mesenchymal core of the villi, and the HGFR has been detected in the mitotic cytotrophoblasts [6] [7] [8] [9] [10] . A decrease in the level of HGF is associated with preeclampsia and IUGR [8, 11] and with lessened placental growth [12] .
The HGFR has been identified as the c-met protooncogene, a transmembrane tyrosine kinase [7, 13] . The receptor RON/stk is homologous to c-met and binds HGF-like protein/macrophage stimulatory protein (MSP), which is related to HGF [14] ; however, there is no cross-reactivity between HGF and MSP.
In the mouse, pregastrulation development (before E6.5) has the following sequence: 1) cleavage occurs in the first six cell divisions, leading to the generation of trophoblast cells (a placental lineage), embryonic ectoderm, and primitive endoderm (an extraembryonic yolk sac precursor); and 2) implantation of the embryo at E4.5 is mediated by the interaction of the trophoblast cells with the endometrium and subjacent basement membrane [1, 15, 16] . At gastrulation, extra-embryonic mesoderm produces the allantois that invests the chorion to form the chorioallantoic placenta.
We hypothesize that HGF in the mouse has an important role in the development of the placenta before the lethality due to placental failure of the hgf and hgfr null mutants. In this study, our objectives were 1) to determine when the first effect of HGF on placental function occurred, 2) to test for the location of the HGF sources, 3) to investigate whether the effects were directly upon placental lineage cells, and 4) to investigate whether the effects were primarily upon cell division and/or differentiation.
We report here that murine HGF is expressed in uterine tissue that is likely to influence the earliest placenta precursors and that HGF causes growth and limits the differentiation of the earliest placenta precursors from the implanting blastocyst.
MATERIALS AND METHODS

Materials
Amplitaq DNA polymerase was purchased from PerkinElmer Cetus (Norwalk, CT). Restriction enzymes and T4 polynucleotide kinase were purchased from New England BioLabs (Beverly, MA) and Gibco/BRL (Gaithersburg, MD). Radioisotopes were obtained from New England Nu- in B, lane 1) copies were detectable. The arrowhead shows the HGF amplimer at 322 bp (A) and the HGFR amplimer at 133 bp (B). From left to right in A, the blastocyst outgrowths are E3.5 ϩ3, ϩ4, and ϩ5 days. From left to right in B, the blastocyst outgrowths are the same as in A, and the fourth Bo is E3.4 ϩ5. The equivalent time after fertilization is also given as E0.5, E4.5 (implantation), and E6.5 (at the start of gastrulation) for comparing with in situ hybridization in Figures  3, 4 , and 5. M, Marker; 1, unfertilized one-cell ova; 2 and 8, cell number in the embryo; B, blastocyst; Bo, blastocyst outgrowth; Ut, E5.5 uterus; C, PCR control (FGFR-1 plasmid at 274 bp in A). Markers in A are from a 1-kb ladder (the 517 and 506 pair and 201 and 220 pair do not resolve) and in B are a 123-bp ladder.
clear (Boston, MA) or Amersham (Arlington Heights, IL). Moloney murine leukemia virus (MMLV) reverse transcriptase and superscript MMLV reverse transcriptase was obtained from Gibco/BRL. Oligonucleotides for the polymerase chain reaction (PCR) were synthesized in our laboratory on an Applied Biosystems PCR-Mate oligosynthesizer (Foster City, CA) or at the Biotech Facility at Northwestern University. The PCRII cloning kit was from Invitrogen (San Diego, CA). Digoxigenin-UTP Genius RNA labeling kit, anti-digoxigenin-alkaline phosphatase conjugate, nitro blue tetrazolium (NBT), and X-phosphate (5-bromo-4-chloro-3-indolyl phosphate) were all from Boehringer-Mannheim Biochemicals (Indianapolis, IN). Hoechst 33258 and NTB2 emulsion were purchased from Eastman Kodak Company (Rochester, NY). All other chemicals were from Sigma Chemical (St. Louis, MO) or VWR (Chicago, IL). Agarose was from FMC (Rockland, ME). TROMA-1 antibody was obtained from the Iowa Developmental Biology Hybridoma Bank. Antibodies to laminin were obtained from ICN (Costa Mesa, CA), antibodies to proliferating cell nuclear antigen (PCNA) were obtained from (Santa Cruz Biotech, Santa Cruz, CA), and placental lactogen (PL)-1 antibody was a kind gift of Dr. D.I.H. Linzer (Northwestern University, Chicago, IL) [17] . The HGFR cDNA clone (pCDM1) and HGF cDNA clone (pHGF) and anti-HGFR antibody were gifts of Dr. A. Iyer (Northwestern University Medical School, Chicago, IL) [18, 19] .
Mouse Eggs and Embryos
Standard techniques were used for obtaining zygotes [20] by breeding female CD-1 (6-10 wk old, Charles River, Wilmington, MA) or MF-1 (Harlan Sprague Dawley, Indianapolis, IN) C57BL/6J ϫ SJL/J F 1 hybrid males (Jackson Laboratories, Bar Harbor, ME). Noon of the day following coitus was considered Day E0.5. Embryos were obtained at the following stages: 2-cell stage (E1.0), 8-cell stage (E2.0), early cavitation blastocyst (E3.5), late cavitation blastocyst (E4.5), and blastocyst outgrowths equivalent to E5.5 and E6.5 [21] . The animal use protocols were approved by the Northwestern University Institutional Care and Use Committee (IACUC). Embryos were sectioned from the uteri of females at E5.5 through E8.5 [22] .
Cell and Embryo Culture
TC-2 cells were derived from NIH3T3 cells by stable expression of an HGFR gene under promotion of a viral long terminal repeat [19] . For blastocyst outgrowths, blastocysts were isolated and cultured as previously described [21, 23] . In all experiments, single blastocysts were placed in 5-l droplets with medium alone or medium that contained 10 ng/ml recombinant human HGF (a gift of Genentec, S. San Francisco, CA)). This dose was found to be optimal in other tests of HGF function (data not shown). Blastocysts were cultured for 20-96 h, and the outgrowth size and number of trophoblast cells were analyzed as described previously [23] . All experiments were repeated at least two times. In some cases, blastocyst outgrowths were also assayed for expression of TROMA-1, PL-1, or HGFR by immunocytochemical means (see below).
In Situ Hybridization
HGF and HGFR inserts of 2.6 kilobases (kb) and 0.68 kb in size, respectively, were subcloned into pGEM, and in situ hybridization was carried out as previously published [22] . Grain counting was performed using Image J 1.08i (NIH Image for PC; Bethesda, MD), with analysis using a pixel cluster range of 7-24, and sampling with a rectangle sampling tool with dimensions of 0.35 ϫ 0.05 arbitrary units.
Statistical Analysis
A Student's two-tailed t-test was used to analyze the effects of HGF on PCNA expression, Pl-1 expression, and 
Reverse Transcription (RT)-Polymerase Chain Reaction (PCR)
RNA was purified from preimplantation embryos and blastocyst outgrowths, and the RT-PCR was done as described previously [21, 23] . Embryo samples were normalized to actin content before experimental transcripts were tested. The PCR primers (5 prime, 1915-1932 nucleotides (nt); 3 prime, 2214-2236 nt in the mouse HGF sequence [24] ) produced an amplimer that was 322 base pairs (bp) long. The PCR primers for the HGFR (5 prime, 4278-4298 nt; 3 prime, 4393-4410 [18] ) produced a product that was 133-bp long. The HGF product was cut with BclI, producing the predicted fragments of 23 and 299 bp. The HGFR product was cut with HaeIII, producing the predicted fragments of 31 and 102 bp. The plasmids pHGF and pCDM1 were used to control for the sensitivity of the PCR reaction. The mixture was amplified for 50 cycles on a Perkin-Elmer Cetus Thermocycler 9600 programmable heating block as described previously [21] . All RT reactions were checked with primers to actin (which span introns) for contamination of the RNA with DNA.
Indirect Immunocytochemistry and Nuclear Staining
For immunocytochemical analysis, blastocyst outgrowths were prepared as previously described ( [21, 23, 25] , except that fixation for PCNA was done with 4:1 dimethyl sulfoxide:methanol). The blastocysts were stained with rabbit polyclonal anti-mouse HGFR carboxyl terminus, rabbit polyclonal anti-laminin ( [19] . The anti-HGFR antiserum was tested for specificity on TC-2 cells that were stably transfected with HGFR [19] . To control for antibodies, normal rabbit serum (1:200) or NS-1 myeloma supernatant (at 1:5; for control of hybridoma antibodies obtained from the Iowa Developmental Hybridoma Bank) were incubated with blastocyst outgrowths for 2 h. The primary antibody was followed by staining with biotinylated antirabbit IgG or biotinylated anti-mouse IgG (Fisher Scientific, Pittsburgh, PA, or Southern Biotechnology, Birmingham, AL) and then by alkaline phosphatase-coupled streptavidin (Vector Labs., Burlingame, CA) as described previously [21] . An insoluble product was developed by using bromochloro-indolyl phosphate and nitroblue tetrazolium (Vector). In some experiments, TROMA-1, HGFR, PCNA, or laminin were visualized with Texas Red or fluorescein isothiocyanate (FITC) coupled to streptavidin (Vector). Nuclear counterstaining was done with Hoechst 33258. Photomicrography was done with a Nikon Microphot-FXA microscope (Nikon, Inc., Melville, NY). Micrographs were taken with epifluorescence as previously described [21, 23] . Some photomicrography was done with a Zeiss (Thornwood, NJ) epifluorescence microscope controlled electronically by Smart-Capture software (Vysis, Downers Grove, IL), captured digitally using three elements of a Ludi filter wheel (Vysis). Photomicrographs were formatted using Adobe Photoshop 3.0 (San Jose, CA).
RESULTS
HGFR, but Not HGF, mRNA Was Detected in Periimplantation Mouse Embryos by RT-PCR
Preimplantation embryos and postimplantation blastocyst outgrowths were tested for expression of HGF and FIG. 3. HGF mRNA was detected in the mesometrial decidua from E6.5 through E8.5. Deciduae (A-F) were fixed, embedded, sectioned, and probed for HGF by 35 S in situ hybridization. Panels A, C, and E are darkfield micrographs of HGF hybridized sections, and B, D, and F are the respective sections with hematoxylin and eosin counterstain. RBC, Areas of accumulated red blood cells; HF, head fold stage embryo. The inset in E shows the approximate area of the in situ hybridization in Figure 4 . Scale bars in A, C, and E show 500 m. Panel G is a E7.5 decidua hybridized with sense HGFL probe, and H is the same section with hematoxylin and eosin counterstain. The orientation of all panels is the same, with the mesometrial decidua (shown in B) at the bottom. Note that E8.5 timed by approximate mating time appears to be E8.0 by morphological criteria.
HGFR mRNA by RT-PCR. HGF mRNA was not detected in preimplantation mouse embryos or in blastocyst outgrowths, but it was detected in E5.5 mouse uteri (Fig. 1A) . HGFR mRNA was detected in unfertilized ova and in preimplantation embryos from the 8-cell stage to the blastocyst stage and in blastocyst outgrowths (Fig. 1B) . The 2-cell embryos were always negative (Fig. 1B and data not  shown) , but the 8-cell embryos were only sometimes negative. This suggests that the expression of HGFR was near the level of sensitivity of detection of the assay (1000 copies of HGFR plasmid; Fig. 1B) . A second possibility is that HGF receptor is not transcribed efficiently during RT. The variability in the strength of the HGFR is not understood.
HGFR Protein Was Detected in Trophoblast Cells in Blastocyst Outgrowths
Blastocyst outgrowths were tested for the expression of the HGFR protein. Blastocyst outgrowths are used as an in vitro model for studying implantation. Although the morphology is not the same as that of the embryo in utero, many of the processes of placental formation occur similarly [28] . Under these culture conditions, primary trophoblast giant cells (TGC) grow out from the blastocyst at 1-3 days of culture. Blastocysts cultured for 4-6 days produce TGC and a smaller population of laminin-positive parietal endoderm cells [21] . At three days of culture, HGFR was detected by immunocytochemical means in outgrowing trophoblast cells (Fig. 2) . HGFR protein was detected variably during the maturation of trophoblasts, with cells with small nuclei near the inner cell mass (ICM) expressing HGFR and outer trophoblasts expressing HGFR more variably. This variability may have been due to degradation of receptor protein during maturation or to spreading of the TGC, with an apparent decrease in receptor protein concentration.
HGF mRNA Was Detected in the Mesometrial Decidua by In Situ Hybridization
Since HGF was not detected in the periimplantation embryos and blastocyst outgrowths from E0.5-6-5, but was detected in the E5.5 uterus by RT-PCR, we tested for a maternal source of HGF in the decidua by in situ hybridization using 35 S and alkaline phosphatase-mediated development. The cDNA for HGF and for HGFR were previ-FIG. 4. HGF mRNA was detected in the allantois, and HGFR mRNA was detected in the chorionic placenta at the time of chorioallantoic fusion at E8.0. Decidua was fixed, embedded, sectioned, and probed for HGFR (A, B) and HGF (C, D) mRNA by in situ hybridization using alkaline phosphatase for development of stain. Panels B and D show the Hoechst counterstain for A and C, respectively. Panels E and G show the controls using sense strand HGFR and HGF as hybridization probes, and F and H show the Hoechst counterstain, for E and G, respectively. Al, Allantois; CP, chorionic placenta; HGFR, HGF, receptor; HGFL, HGF ligand; sense, control hybridizations; Hoechst, counterstain shown on F only, but also in B, D, and H. ously shown to be specific for HGF and HGFR [22] . The probes do not detect HGF-like protein mRNA or the RON/ stk receptor, respectively.
HGF mRNA was detected in the mesometrial end of the decidua from E6.5-8.5 (Fig. 3) . HGF mRNA was not detected at E5.5 by in situ hybridization, but it was detected by RT-PCR (Fig. 1) . Since HGF mRNA was not detected in the blastocyst outgrowth after implantation (Fig. 1) , the source of the HGF mRNA was the E5.5 uterus, and the signal was below the threshold of in situ hybridization. The HGF mRNA was detected in mesometrial mesenchyme that had not undergone the decidual reaction and was not yet highly vascularized, but where vascular sprouts have been noted [29] . In all cases of E6.5-8.5 decidua studied, the ectoplacental cone or chorion was within 500 m of the decidual HGF.
HGF mRNA was first detected in embryo-derived tissue in the allantois at E8.5 (Fig. 4) , a time when the HGFR mRNA was detected in the adjacent chorion. This is in agreement with previous data suggesting that the wild type, but not hgf null, allantois is trophic for chorionic placenta [4] .
HGF mRNA was not detected in the myometrium or the epithelia of the endometrium, but it was detected in the mesenchyme at high levels (Fig. 5) . To quantitate the differences in expression, grain counts for tissue types in the decidua were taken. For an arbitrary area in Figure 5A , there were 6.1 Ϯ 1.4 grains in the myometrium compared with 28.9 Ϯ 1.7 grains in the mesenchyme; for Figure 5B there were 14.5 Ϯ 2.1 grains in the epithelium compared with 34.3 Ϯ 1.9 grains in the mesenchyme; for Figure 5C there were 11.2 Ϯ 1.1 grains in the epithelium compared with 37.4 Ϯ 2 grains in the mesenchyme, and for Figure  5D there were 9.5 Ϯ 1.8 grains in the epithelium compared with 31.1 Ϯ 1.2 grains in the mesenchyme. Significantly fewer grains were generated by HGF probe hybridization (P ϭ 0.001) in myometrium or epithelium in (Fig. 5 , A-D) compared with mesenchyme. This suggests that HGF is expressed in the mesenchyme but not epithelium, as has been observed previously [6, 7] .
HGF Stimulated a Time-Dependent Increase in Outgrowing Trophoblasts and Limited Their Differentiation to TGC
To test whether HGF can have an effect on early mouse embryos, blastocysts were flushed from uteri at E3.5 and cultured in Ham's F-12 with 4% fetal calf serum with or without 10 ng of recombinant HGF. The attached blastocysts and outgrowing cells were fixed and stained with Hoechst and photographed, and the nuclei in the outgrowth were counted. Significantly more nuclei were detected in the outgrowth when HGF was present during culture ( Fig.  6A ; P Յ 0.05). These effects were modest yet significant. The level of significance by t-test and the level of stimulation were similar to those caused by FGF-4, which is essential for trophoblast growth at implantation [23, 30] . Since the nuclei in the densely packed ICM could not be counted, this increase in number of outgrowing cells could be due to a scattering of ICM cells or real growth in the number of outgrowing cells. To test this further, the number of cells in S phase were assayed for expression of PCNA protein [25] . Significantly more outgrowing cells expressed PCNA in the HGF-stimulated blastocyst outgrowths (Fig.  6B , HGF, 18 Ϯ 6.4, vs. medium, 10.8 Ϯ 3.1; P ϭ 0.03). This suggests that HGF stimulates cell division in outgrowing trophoblasts.
HGF stimulated a significant increase in S phase trophoblasts and total trophoblast number. Some of the increase in trophoblast number could be due to scattering; however, there was no increase in outgrowing cells within 24 h of addition of HGF to the blastocyst culture (Fig. 6C) . The effect of HGF as a scatter factor occurs within 20 h [31] and in as little as 8 h in dispersing ectoderm at gastrulation (unpublished data), suggesting that HGF was not acting as a scatter factor in the blastocyst outgrowths. The same outgrowths were assayed for surface area. At 20 h after Time 0, there was no increase in cell numbers in the outgrowth or outgrowth surface area (Fig. 6D) . After 48 h of stimulation with HGF, blastocyst outgrowths had significantly larger areas (Fig. 6D, r ϭ 0.32 ), but this increase in area was proportional to the increased number of nuclei in the outgrowth (Fig. 6, C and D, r ϭ 0.88) . These data suggest that HGF does not act as a scatter factor but as a timedependent mitogen for trophoblasts.
To test which cells responded to HGF, we used morpho-FIG. 5. HGF was detected in the mesenchyme, but not myometrium or epithelium of the mesometrial decidua. E8.5 stage decidua was fixed, embedded, sectioned, and probed for HGF by 35 S in situ hybridization with antisense cRNA. In A-D, high-magnification (each panel is 1500 m across) micrographs of H&E counterstained mesometrial decidua show grains produced by hybridization shown in transmitted light. All panels shown mesenchymal staining (white arrows), and less or no staining is shown (black notched arrowhead) for myometrium (A), longitudinal endometrial glandular epithelium (B), cross section of endometrial glandular epithelium (C), and epithelium of lacunae (D). Grain counts of equal areas of multiple samples for each panel are given in Results.
FIG. 6. HGF stimulated an increase in outgrowing PCNA-expressing trophoblast cells in a time-dependent manner. Blastocysts were isolated at E3.5, cultured on fibronectin-coated coverslips for 1-5 days, fixed, stained with PCNA antibody, and Hoechst-counterstained, and the nuclei of outgrowing cells were counted. The outgrowing cells were ENDO Apositive and laminin-negative (data not shown), indicating that they were trophoblasts. HGF caused an increase in A) outgrowing trophoblast cells and B) the number of PCNA-positive trophoblasts at E3.5 ϩ4. In a separate experiment from A and B, HGF caused a time-dependent increase in the surface area of the outgrowth that was proportionate to the number of cells (C, D) . In C and D, diamonds show HGF-stimulated blastocyst outgrowths, and squares show those grown in medium. In A-D, error flags show standard error of the mean.
logical and immunocytochemical assays. Many of the outgrowing cells were morphologically distinct TGC. All of the outgrowing cells expressed cytokeratin (ENDO A) antigen, which is expressed primarily in trophectoderm; it is also expressed in outgrowing parietal endoderm cells ( [26, 27, 32] ; data not shown). However, the outgrowing cells did not express laminin, a protein secreted by parietal endoderm cells ( Fig. 2; [21] ).
To assay for the effects of HGF upon differentiation of TGC, we assayed blastocyst outgrowths for the fraction and total number of cells expressing PL-1 [33] . The number of cells responding to HGF increased significantly (P ϭ 0.04), but HGF significantly decreased the total number and fraction of PL-1-positive outgrowing cells (Fig. 7 , B and C; P ϭ 0.03 and P ϭ 0.01, respectively). This suggests that HGF increases mitosis while slowing and suppressing differentiation of trophoblasts.
DISCUSSION
HGF Derived from the Uterus Acts as a Trophoblast Growth Factor Early After Implantation
In this report, we show that HGFR mRNA and protein were detected in the implanting embryo and that HGF mRNA was detected in the uterine stroma after implantation, but before the start of gastrulation at E6.5. Interestingly, HGFR was not detected in preimplantation human embryos [8] . The difference in our findings and those in humans may be due to a species difference or to a lack of sensitivity of the PCR in the testing of smaller numbers of human embryos. HGF was first detected in embryo-derived tissue in the allantois after the start of gastrulation. In the blastocyst outgrowths, HGF stimulated an increase in the number of outgrowing trophoblast cells in postimplantation-, pregastrulation-stage embryos, but it did not cause scattering. HGF limited the fraction and total number of trophoblast cells that differentiated to TGC. The data suggest a paracrine or juxtacrine role for maternally derived HGF in regulating periimplantation mouse trophoblast growth. HGF function begins six days before the lethality of the hgf null mutant and three days before the first stimulation of placental growth ( Fig. 7; [4] ). The data suggest that maternal HGF may delay the onset of lethality of the HGF null.
HGF Acts to Increase the Number of Early Trophoblast Cells but Not Giant Cells
The cells growing out from the blastocysts were trophoblast cells as determined by several criteria. Morphologically, the size of the nuclei of outgrowing cells increased with time and appeared to correspond with the endoredu- [18, 42] (with permission), with the conclusion about the E8.0 allantois mediation of growth of the chorionic placenta from Uehara et al. [4] .
plication that occurs in TGC [1] . The large outgrowing cells also expressed the cytokeratin ENDO A, detected by TRO-MA-1 antibody [26, 27] , a marker for trophoblasts cells during formation of the blastocyst, which is also expressed in endodermal cells. However, these cells did not express laminin and therefore were not endoderm cells. HGF caused a significant decrease in the number and fraction of PL-1-expressing cells observed in the blastocyst outgrowth. PL-1 is detected early during trophectoderm differentiation to TGC in the implanting E4.5 blastocyst and blastocyst outgrowth [33, 34] . It is not clear if the suppression of the increase in PL-1-expressing cells is due to a transient expansion of earlier mitotic trophoblast cells or a suppression of TGC differentiation.
HGF Does Not Act as a Scatter Factor for Trophoblast Cells In Vitro
HGF can be a growth factor for liver cells and vascular endothelial cells, and a scatter factor for epithelial cells [6, 7] . Two lines of evidence suggest that HGF acts as a growth factor and not as a scatter factor for early placental precursor cells. First, the induction of an increase in number of cells in the blastocyst outgrowth and in area of the outgrowth was first seen at 48 h, but not at 20 h, although the HGFR was detectable in the unhatched blastocyst at low levels. In contrast, the scattering effect seen in cultured cells and embryos occurs within 6 h of addition of HGF ( [31] and unpublished data). Second, during the blastocyst outgrowth, the increase in area of the outgrowth was proportional to the increase in the number of cells in the outgrowth.
Effects of HGF Are Complex and Include Induction of Trophoblast Growth and Angiogenesis in the Placenta and Decidua
HGF stimulated trophoblast growth, but not differentiation, between E5.5 and E8.5 (Fig. 8) . Decidual HGF was detected by RT-PCR at E5.5, but not by in situ hybridization, and its location is not known. But from E6.5-8.5, mesometrial HGF is sufficiently near (500 m) to diffuse and stimulate placental growth [35] . In humans, first-trimester cytotrophoblasts are stimulated to grow out in vitro by HGF [36] . In the mouse, mesenchyme-derived HGF in the allantois is a growth factor for chorionic placenta at E8.5 [4] . Later during human placental development, placental villous core mesenchyme synthesizes HGF [10, 36] . This HGF source is thought to be angiogenic in the mouse [17] and growth-inducing for cytotrophoblasts in the human [36] . A decrease in villous HGF may contribute to placental insufficiency diseases such as preeclampsia and intrauterine growth retardation in humans [8] [9] [10] 36] .
The function of the endometrial/decidual HGF is less clear. If HGF is near the implantation site at E4.5, it is not angiogenic. The highest density of uterine capillary beds is near the implanting blastocyst, but there is no evidence for neovascularization at this site. The increase in vascular permeability at the implantation site is associated with a dilation of vessels without evidence of vascular growth [37] [38] [39] . In contrast, HGF binds endothelial cells and causes growth but does not induce the vascular cell adhesion molecule, endothelial cell-leukocyte adhesion molecule, or platelet activating factor, markers of activated, inflammatory, and permeable endothelial cells [5] .
By E8.5, mesometrial HGF is likely to be angiogenic. It is synthesized during early decidualization and precedes mesometrial angiogenesis. The general distribution of HGF in the mesometrial pole matches that for vascular sprouts as measured by morphology and Dolichos biflorus lectin binding during E6.5-8.5 [16, 29] . It is interesting to note that HGF expression precedes the expression of osteopontin in the mesometrium [40] . Osteopontin is involved with angiogenic sprouting and the adhesion of migrating endothelial cells, and is induced by HGF in liver cells ( [41] ; Dr. A. Iyer, personal communication).
The mesometrial HGF may act as a chemoattractant for the growing placenta in the implantation chamber. Since there is no deficiency in early trophoblast growth or migration in the hgfr null mutant, the role of maternal HGF is not essential. In rodents, the placenta is not as invasive as in humans. The implanting embryo [15, 16] and decidua induce apoptosis in the uterine epithelium. At this point, the trophoblast grows and migrates out along the basement membrane of the denuded epithelium towards the mesometrial decidua. HGF in the mesometrial uterus may facilitate this directed growth.
In summary, the data suggest that mesometrial HGF is stimulatory for angiogenesis in the placenta (and may be for the decidua) and that HGF stimulates trophoblast growth in humans and mice soon after implantation.
Summary: HGF and Other Growth Factors Control the Earliest Division of Trophoblasts
We conclude that HGF has effects on cell division for trophoblasts in the postimplantation mouse embryo. The data presented here suggest that the mitogenic effects of HGF are direct, and independent of the known effects of HGF upon angiogenesis [17] that may contribute to the later lethality in the hgf null mutant [4] . This report also suggests that HGF is supplied to the implanting embryo uniquely from maternal sources.
Several growth factors affect the division of periimplantation trophoblasts. In contrast to HGF, colony-stimulating factor-1 and insulin-like growth factors also stimulate placental growth, but they are not essential for embryonic survival [2, 3] . In contrast to HGF, FGF is necessary for trophoblast proliferation and embryo survival earlier than HGF (before implantation; [23] ), requires other diffusible factor(s) [30] , and is supplied uniquely from embryonic sources. HGF may be one of the set of diffusible factors needed for trophoblast division.
